$0.7672
-0.00280-0.36%
At close: -
$0.7568
-0.01-1.36%
After Hours: Apr 11, 4:00 PM EDT
Comments
Loading...
Alzamend Neuro (ALZN) Forecast
NewsEarningsAlzamend Neuro (ALZN) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Alzamend Neuro Stock Price, Quotes and Forecasts | NASDAQ:ALZN | Benzinga
Explore Alzamend Neuro stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for ALZN.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Alzamend Neuro (ALZN) stock?
You can purchase shares of Alzamend Neuro (NASDAQ:ALZN) through any online brokerage.
Who are Alzamend Neuro (ALZN) competitors?
Other companies in Alzamend Neuro’s space includes: Dermata Therapeutics (NASDAQ:DRMA), Can Fite Biofarma (AMEX:CANF), NuCana (NASDAQ:NCNA), Indaptus Therapeutics (NASDAQ:INDP) and Ocean Biomedical (NASDAQ:OCEA).
What is the forecast, or price target, for Alzamend Neuro (ALZN) stock?
Alzamend Neuro has a consensus price target of $10.75.
What is the current price for Alzamend Neuro (ALZN)?
The stock price for Alzamend Neuro (NASDAQ: ALZN) is $0.7568 last updated April 11, 2025 at 4:00 PM EDT.
Does Alzamend Neuro (ALZN) pay a dividend?
There are no upcoming dividends for Alzamend Neuro.
When is Alzamend Neuro (NASDAQ:ALZN) reporting earnings?
Alzamend Neuro’s Q3 earnings are confirmed for Monday, March 10, 2025.
Is Alzamend Neuro (ALZN) going to split?
There is no upcoming split for Alzamend Neuro.
What sector and industry does Alzamend Neuro (ALZN) operate in?
Alzamend Neuro is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.